Find where to buy products from UK suppliers, including: distributors, industrial manufacturers, wholesalers, raw ingredients, bulk supplies and finished goods for sale.
Search for products or services, then visit the suppliers website for prices, SDS or more information. You can also view suppliers in Australia, NZ or the USA.
| Product | Description | |
|---|---|---|
| (2S,4R)-N-((S)-2-(tert-Butyl)-17-((S)-4-(4-chlorophenyl)-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl)-4,16-dioxo-6,9,12-trioxa-3,15-diazaheptadecan-1-oyl)-4-hydroxy-1-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide | (2S,4R)-N-((S)-2-(tert-Butyl)-17-((S)-4-(4-chlorophenyl)-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl)-4,16-dioxo-6,9,12-trioxa-3,15-diazaheptadecan-1-oyl)-4-hydroxy-1-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide is a linker widely used in antibody-drug conjugates (ADCs). Group: Pharmaceutical. Alternative Names: (2S,4R)-1-[(2S)-2-[[2-[2-[2-[2-[[2-[(9S)-7-(4-chlorophenyl)-4,5,13-trimethyl-3-thia-1,8,11,12-tetrazatricyclo[8.3.0.02,6]trideca-2(6),4,7,10,12-pentaen-9-yl]acetyl]amino]ethoxy]ethoxy]ethoxy]acetyl]amino]-3,3-dimethylbutanoyl]-4-hydroxy-N-[[4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]pyrrolidine-2-carboxamide. CAS No. 1797406-69-9. Pack Sizes: 10 mg. Product ID: BADC-01565. Molecular formula: C49H60ClN9O8S2. Mole weight: 1002.64. Custom synthesis is available. Send your inquiries for more information. |  London |
| N'-[(6-Methyl-2-pyridyl)methylene]pyrrolidine-1-carbothiohydrazide | N'-[(6-Methyl-2-pyridyl)methylene]pyrrolidine-1-carbothiohydrazide, a chemical entity with an aptitude for disrupting tumor metastasis, has recently proven to be quite efficacious. Its ability to suppress the growth of various cancerous cells has been demonstrated in numerous studies. When used judiciously, this agent could be quite promising in the treatment of cancer, opening up alternate therapeutic avenues. Group: Pharmaceutical. Alternative Names: 1-Pyrrolidinecarbothioic acid, [(6-methyl-2-pyridinyl)methylene]hydrazide; N'-[(6-Methyl-2-pyridinyl)methylene]-1-pyrrolidinecarbothiohydrazide. CAS No. 907549-72-8. Pack Sizes: 10 mg. Product ID: B0001-284865. Molecular formula: C12H16N4S. Mole weight: 248.35. Custom synthesis is available. Send your inquiries for more information. | London |
| 7-Epi Clindamycin | 7-Epi Clindamycin, a highly efficacious antibiotic, exhibits remarkable efficacy against a wide range of bacterial infections. By discerningly impeding protein synthesis within bacterial organisms, it disrupts their growth and obstructs their survival, effectively eliminating the pernicious microorganisms. Distinctively versatile, this compound demonstrates its unwavering effectiveness against both Gram-positive and Gram-negative bacteria. Consequently, this invaluable asset plays an integral role in the biomedical field, diligently combatting infectious ailments with exceptional efficacy. Group: Pharmaceutical. Alternative Names: D-erythro-D-galacto-Octopyranoside, methyl 7-chloro-6,7,8-trideoxy-6-(1-methyl-4-propyl-L-2-pyrrolidinecarboxamido)-1-thio-, trans-α-; D-erythro-α-D-galacto-Octopyranoside, methyl 7-chloro-6,7,8-trideoxy-6-[[(1-methyl-4-propyl-2-pyrrolidinyl)carbonyl]amino]-1-thio-, (2S-trans)-; Methyl 7-chloro-6,7,8-trideoxy-6-[[[(2S,4R)-1-methyl-4-propyl-2-pyrrolidinyl]carbonyl]amino]-1-thio-D-erythro-α-D-galacto-octopyranoside; 7-Epiclindamycin; Antibiotic U 21251F. CAS No. 16684-06-3. Pack Sizes: 5 mg. Product ID: B1370-159244. Molecular formula: C18H33ClN2O5S. Mole weight: 424.98. Custom synthesis is available. Send your inquiries for more information. | London |
| 7-Epi Lincomycin Hydrochloride Salt | 7-Epi Lincomycin Hydrochloride Salt is an epimer of Lincomycin, a 6-amino, 6-deoxy-octopyraninose with strong antibiotic activity. It is less potent bactericidal than its (7R)-epimer. Group: Pharmaceutical. Alternative Names: Methyl 6,8-dideoxy-6-[[[(2S,4R)-1-methyl-4-propyl-2-pyrrolidinyl]carbonyl]amino]-1- thio-L-threo-α-D-galacto-octopyranoside Hydrochloride; trans-α-Methyl 6,8-dideoxy-6-(1-methyl-4-propyl-L-2-pyrrolidinecarboxamido)- 1-thio-L-threo-D-galacto-octopyranoside. CAS No. 26389-84-4. Pack Sizes: 5 mg. Product ID: B2694-472409. Molecular formula: C18H35ClN2O6S. Mole weight: 443. Custom synthesis is available. Send your inquiries for more information. | London |
| ARV-771 | ARV-771 is a potent BET bromodomain PROTAC® Degrader based on von Hippel-Lindau (VHL) E3 ligase, consisting of a BRD4-binding moiety bound to a VHL ligand via a linker. Group: Pharmaceutical. Alternative Names: ARV 771; ARV771; (2S,4R)-1-((S)-2-(tert-butyl)-15-((S)-4-(4-chlorophenyl)-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl)-4,14-dioxo-6,10-dioxa-3,13-diazapentadecanoyl)-4-hydroxy-N-((S)-1-(4-(4-methylthiazol-5-yl)phenyl)ethyl)pyrrolidine-2-carboxamide; L-Prolinamide, N-[2-[3-[2-[[2-[(6S)-4-(4-chlorophenyl)-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl]acetyl]amino]ethoxy]propoxy]acetyl]-3-methyl-L-valyl-4-hydroxy-N-[(1S)-1-[4-(4-methyl-5-thiazolyl)phenyl]ethyl]-, (4R)-; N-({3-[2-({[(6S)-4-(4-Chlorophenyl)-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl]acetyl}amino)ethoxy]propoxy}acetyl)-3-methyl-L-valyl-(4R)-4-hydroxy-N-{(1S)-1-[4-(4-methyl-1,3-thiazol-5-yl)phenyl]ethyl}-L-prolinamide. CAS No. 1949837-12-0. Pack Sizes: 5 mg. Product ID: B2693-007297. Molecular formula: C49H60ClN9O7S2. Mole weight: 986.64. Custom synthesis is available. Send your inquiries for more information. | London |
| Auristatin F | Auristatin F, a synthetic analog of dolastatin 10, is a cytotoxic tubulin modifier with potent and selective antitumor activity. It is an MMAF analog and cytotoxin in Antibody-drug conjugates. Uses: Adcs cytotoxin. Group: Pharmaceutical. Alternative Names: N,N-Dimethyl-L-valyl-L-valyl-(3R,4S,5S)-3-methoxy-5-methyl-4-(methylamino)heptanoyl-(αR,βR,2S)-β-methoxy-α-methyl-2-pyrrolidinepropanoyl-L-phenylalanine; L-Valinamide, N,N-dimethyl-L-valyl-N-[(1S,2R)-4-[(2S)-2-[(1R,2R)-3-[[(1S)-1-carboxy-2-phenylethyl]amino]-1-methoxy-2-methyl-3-oxopropyl]-1-pyrrolidinyl]-2-methoxy-1-[(1S)-1-methylpropyl]-4-oxobutyl]-N-methyl-; N,N-Dimethyl-L-valyl-N-[(3R,4S,5S)-1-{(2S)-2-[(1R,2R)-3-{[(1S)-1-carboxy-2-phenylethyl]amino}-1-methoxy-2-methyl-3-oxopropyl]-1-pyrrolidinyl}-3-methoxy-5-methyl-1-oxo-4-heptanyl]-N-methyl-L-valinamide. CAS No. 163768-50-1. Pack Sizes: 25 mg. Product ID: BBF-05829. Molecular formula: C40H67N5O8. Mole weight: 745.99. Custom synthesis is available. Send your inquiries for more information. | London |
| Clindamycin 2-Phosphate | Clindamycin Phosphate is a lincosamide antibiotic for Plasmodium falciparum with IC50 of 12 nM. It is usually used to treat infections with anaerobic bacteria, but can also be used to treat protozoal diseases, such as malaria. It is a common drug used to treat topical acne and can be effective against some methicillin-resistant Staphylococcus aureus (MRSA) infections. An impurity of Clindamycin. Group: Pharmaceutical. Alternative Names: Methyl 7-Chloro-6,7,8-trideoxy-6-trans-(1-methyl-4-propyl-L-2-pyrrolidine-carboxamido)-1-thio-L-threo-α-D-galactooctopyranoside 2-(Dihydrogen Phosphate); 7(S)-Chloro-7-deoxylincomycin 2-Phosphate; Cleocin T; Cleocin Phosphate; Clinadac; Clindagel; Clindesse; Clindets; Dalacin P; Dalacin T; NSC 618653. CAS No. 24729-96-2. Pack Sizes: 100 g. Product ID: BBF-04542. Molecular formula: C18H34ClN2O8PS. Mole weight: 504.96. Custom synthesis is available. Send your inquiries for more information. | London |
| Dermorphin | Dermorphin, a naturally occurring heptapeptide originally found in the skin of amphibians, is a μ-opioid receptor(MOR) agonist with analgesic and antinociceptive effects. Group: Pharmaceutical. Alternative Names: H-Tyr-D-Ala-Phe-Gly-Tyr-Pro-Ser-NH2; L-tyrosyl-D-alanyl-L-phenylalanyl-glycyl-L-tyrosyl-L-prolyl-L-serinamide; (S)-N-((S)-1-amino-3-hydroxy-1-oxopropan-2-yl)-1-((2S,8S,11R,14S)-14-amino-8-benzyl-2-(4-hydroxybenzyl)-15-(4-hydroxyphenyl)-11-methyl-4,7,10,13-tetraoxo-3,6,9,12-tetraazapentadecane)pyrrolidine-2-carboxamide. CAS No. 77614-16-5. Pack Sizes: 10 mg. Product ID: BAT-006192. Molecular formula: C40H50N8O10. Mole weight: 802.87. Custom synthesis is available. Send your inquiries for more information. | London |
| Diprotin A | It is produced by the strain of Bacillus cereus BMF 657-RF1. It can inhibit Dipeptidyl amino peptidase IV and immune enhancement effect. Group: Pharmaceutical. Alternative Names: Ile-Pro-Ile; isoleucylprolylisoleucine; l-isoleucyl-l-prolyl-l-isoleucine; N-(1-L-Isoleucyl-L-prolyl)-L-isoleucine; isoleucyl-prolyl-isoleucine; L-Isoleucine, N-(1-L-isoleucyl-L-prolyl)-; (2S,3S)-2-((S)-1-((2S,3S)-2-Amino-3-methylpentanoyl)pyrrolidine-2-carboxamido)-3-methylpentanoic acid; H-Ile-Pro-Ile-OH. CAS No. 90614-48-5. Pack Sizes: 500 mg. Product ID: BAT-010802. Molecular formula: C17H31N3O4. Mole weight: 341.45. Custom synthesis is available. Send your inquiries for more information. | London |
| Fmoc-trans-4-methyl-L-Pro-OH | Fmoc-trans-4-methyl-L-Pro-OH. Group: Pharmaceutical. Alternative Names: N-(9-Fluorenylmethoxycarbonyl)-(2S,4R)-4-methylproline; 1-(9H-Fluorene-9-ylmethoxycarbonyl)-4beta-methyl-L-proline; Fmoc-trans-4-Amc-OH; Fmoc-trans-4-methyl-L-proline; (2S,4R)-Fmoc-4-Methyl-L-Pro-OH; (4R)-1-[(9H-Fluoren-9-ylmethoxy)carbonyl]-4-methyl-L-proline; 1,2-Pyrrolidinedicarboxylic acid, 4-methyl-, 1-(9H-fluoren-9-ylmethyl) ester, (2S,4R)-. CAS No. 333777-34-7. Pack Sizes: 50 mg. Product ID: BAT-010883. Molecular formula: C21H21NO4. Mole weight: 351.39. Custom synthesis is available. Send your inquiries for more information. | London |
| Lincomycin hydrochloride | Lincomycin hydrochloride is produced by the strain of Str. lincolnensis var. lincolnensis NRRL 2936. It's a sugar antibiotic. It has anti-gram-positive bacteria and spirochete effect, and has weak antibacterial effect on some gram-negative bacteria. It can protect mice infected with Staphylococcus aureus, Streptococcus hemolyticus and dicoccus pneumoniae by oral or subcutaneous injection. It also has effect on leptospira in vivo. It can prevent and treat respiratory diseases, such as Haemophilus parasuis, infectious pleuropneumonia, mycoplasmosis, atrophic rhinitis, etc. Group: Pharmaceutical. Alternative Names: (2S-trans)-Methyl 6,8-Dideoxy-6-[[(1-methyl-4-propyl-2-pyrrolidinyl)carbonyl]amino]-1-thio-D-erythro-α-D-galactooctopyranoside Hydrochloride; trans-α-Methyl 6,8-dideoxy-6-(1-methyl-4-propyl-L-2-pyrrolidinecarboxamido)-1-thio-D-erythro-D-galacto-Octopyranoside Monohydrochloride; Lincocin; Lincogap; NSC 70731; U 10149a. CAS No. 859-18-7. Pack Sizes: 1mg;1g;10g. Product ID: BBF-02653. Molecular formula: C18H35ClN2O6S. Mole weight: 443. Custom synthesis is available. Send your inquiries for more information. | London |
| Micafungin Open-Ring Analog Sodium salt | Micafungin Open-Ring Analog Sodium salt is an impurity of Micafungin, an echinocandin antifungal drug which inhibits the synthesis of 1,3-β-D-glucan, an essential component of the fungal cell wall, and represent a valuable treatment option for fungal infections. Group: Pharmaceutical. Alternative Names: 5-((1S,2S,3S)-4-(((2S,3R)-5-Amino-1-((2S,3S,4S)-2-carbamoyl-3-hydroxy-4-methylpyrrolidin-1-yl)-3-hydroxy-1,5-dioxopentan-2-yl)amino)-3-((2S,4R)-1-(((2S,4R)-4,5-dihydroxy-1-(4-(5-(4-(pentyloxy)phenyl)isoxazol-3-yl)benzoyl)pyrrolidine-2-carbonyl)-L-threonyl)-4-hydroxypyrrolidine-2-carboxamido)-1,2-dihydroxy-4-oxobutyl)-2-hydroxyphenyl hydrogen sulfate, Sodium Salt. CAS No. 539823-82-0. Pack Sizes: 10 mg. Product ID: B1370-071106. Molecular formula: C56H70N9NaO23S. Mole weight: 1292.26. Custom synthesis is available. Send your inquiries for more information. | London |
| MK-8353 | MK-8353 is an orally available ERK1/2 inhibitor. It exhibited antitumor activity in patients with BRAFV600-mutant melanoma. Group: Pharmaceutical. Alternative Names: (3S)-3-(methylthio)-1-[2-[4-[4-(1-methyl-1,2,4-triazol-3-yl)phenyl]-3,6-dihydro-2H-pyridin-1-yl]-2-oxoethyl]-N-[3-(6-propan-2-yloxy-3-pyridinyl)-1H-indazol-5-yl]-3-pyrrolidinecarboxamide. CAS No. 1184173-73-6. Pack Sizes: 50 mg. Product ID: B2693-291615. Molecular formula: C37H41N9O3S. Mole weight: 691.84. Custom synthesis is available. Send your inquiries for more information. | London |
| MMAF | Monomethyl auristatin F (MMAF) is a synthetic antineoplastic agent. It is part of some experimental anti-cancer antibody-drug conjugates such as vorsetuzumab mafodotin and SGN-CD19A. In International Nonproprietary Names for MMAF-antibody-conjugates, the name mafodotin refers to MMAF plus its attachment structure to the antibody. Uses: Adcs cytotoxin. Group: Pharmaceutical. Alternative Names: Monomethylauristatin F; Monomethyl Auristatin F; N-Methyl-L-valyl-L-valyl-(3R,4S,5S)-3-methoxy-5-methyl-4-(methylamino)heptanoyl-(αR,βR,2S)-β-methoxy-α-methyl-2-pyrrolidinepropanoyl-L-phenylalanine; Monomethylauristatin Phenylalanine; L-Valinamide, N-methyl-L-valyl-N-[(1S,2R)-4-[(2S)-2-[(1R,2R)-3-[[(1S)-1-carboxy-2-phenylethyl]amino]-1-methoxy-2-methyl-3-oxopropyl]-1-pyrrolidinyl]-2-methoxy-1-[(1S)-1-methylpropyl]-4-oxobutyl]-N-methyl-; ((2R,3R)-3-((S)-1-((3R,4S,5S)-4-((S)-N,3-dimethyl-2-((S)-3-methyl-2-(methylamino)butanamido)butanamido)-3-methoxy-5-methylheptanoyl)pyrrolidin-2-yl)-3-methoxy-2-methylpropanoyl)-L-phenylalanine. CAS No. 745017-94-1. Pack Sizes: 10 mg. Product ID: BBF-05779. Molecular formula: C39H65N5O8. Mole weight: 731.48. Custom synthesis is available. Send your inquiries for more information. | London |
| PAR4 (1-6) (human) | PAR4 (1-6) is a synthetic hexapeptide agonist of proteinase-activated receptor 4 (PAR4). PAR4 is a thrombin receptor activated by platelet, and acts as a modulator of cellular responses that serve as hallmarks of inflammation. Group: Pharmaceutical. Alternative Names: H-Gly-Tyr-Pro-Gly-Gln-Val-OH; (2S)-2-[[(2S)-5-amino-2-[[2-[[(2S)-1-[(2S)-2-[(2-aminoacetyl)amino]-3-(4-hydroxyphenyl)propanoyl]pyrrolidine-2-carbonyl]amino]acetyl]amino]-5-oxopentanoyl]amino]-3-methylbutanoic acid. CAS No. 225779-44-2. Pack Sizes: 25 mg. Product ID: BAT-006098. Molecular formula: C28H41N7O9. Mole weight: 619.67. Custom synthesis is available. Send your inquiries for more information. | London |
| phensuximide | Phensuximide is an anticonvulsant drug. It can be used for the treatment of neurological disorders stemming from the brain. Phensuximide can suppress the paroxysmal three cycle per second spike and wave EEG pattern associated with lapses of consciousness in petit mal seizures. Uses: Anticonvulsant. Group: Pharmaceutical. Alternative Names: N-Methyl-2-phenyl-succinimide; (±)-Phensuximide; 1-Methyl-3-phenyl-2,5-pyrrolidinedione; 1-Methyl-3-phenylsuccinimide; Epimid; Lifene; Milontin; Milonton; Mirontin; N-Methyl-2-phenylsuccinimide; N-Methyl-3-phenylpyrrolidinedione; N-Methyl-3-phenylsuccinimide; N-Methyl-α-phenylsuccinimide; PM 334; Phensuximid; Phensuximide; RS-Phensuximide; Racemic Phensuximide; Succitimal. CAS No. 86-34-0. Pack Sizes: 50 mg. Product ID: B0084-078550. Molecular formula: C11H11NO2. Mole weight: 189.21. Custom synthesis is available. Send your inquiries for more information. | London |
| Protein degrader 1 hydrochloride | Protein degrader 1 hydrochloride is a building block used in the synthesis of PROTAC for the recruitment of the von Hippel-Lindau (VHL) protein. Group: Pharmaceutical. Alternative Names: (S,R,S)-AHPC hydrochloride; (2S,4R)-1-((S)-2-Amino-3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide hydrochloride. CAS No. 1448189-80-7. Pack Sizes: 25 mg. Product ID: B0084-007385. Molecular formula: C22H31ClN4O3S. Mole weight: 467.02. Custom synthesis is available. Send your inquiries for more information. | London |
| SR9011 | SR9011, a synthetic REV-ERB agonist, has been found to have probable effect against sleep disorders and metabolic diseases. IC50: 790 nM and 560 nM for Rev-ErbBα and Rev-ErbBβ respectively. Group: Pharmaceutical. Alternative Names: SR 9011; SR-9011; 1-Pyrrolidinecarboxamide, 3-((((4-chlorophenyl)methyl)((5-nitro-2-thienyl)methyl)amino)methyl)-n-pentyl-. CAS No. 1379686-29-9. Pack Sizes: 5 mg. Product ID: B2693-474529. Molecular formula: C23H31ClN4O3S. Mole weight: 479.04. Custom synthesis is available. Send your inquiries for more information. | London |
| (S,R,S)-AHPC-Me | E3 ligase Ligand 1A is a VH032 derivate for conjugation reactions of PROTAC, which can hijack VHL as the E3 ubiquitin ligase component. Group: Pharmaceutical. Alternative Names: (S,R,S)-AHPC-Me; VHL ligand 2; E3 ligase Ligand 1A; 1-(2-amino-3,3-dimethylbutanoyl)-4-hydroxy-N-[1-[4-(4-methyl-1,3-thiazol-5-yl)phenyl]ethyl]pyrrolidine-2-carboxamide. CAS No. 1948273-02-6. Pack Sizes: 1 g. Product ID: B2693-291831. Molecular formula: C23H32N4O3S. Mole weight: 444.59. Custom synthesis is available. Send your inquiries for more information. | London |
| (S,R,S)-AHPC-PEG1-azide | (S,R,S)-AHPC-PEG1-azide is a crosslinker-E3 ligase ligand conjugate consisting of a von Hippel-Lindau (VHL)-recruiting ligand and a PEGylated crosslinker with terminal azide for click chemistry with a target ligand. It has been used as a degrader building block in PROTAC for targeted protein degradation. Group: Pharmaceutical. Alternative Names: E3 ligase Ligand-Linker Conjugates 3; (S,R,S)-AHPC-PEG1-N3; (2S,4R)-1-((S)-2-(2-(2-Azidoethoxy)acetamido)-3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide. CAS No. 2101200-09-1. Pack Sizes: 100 mg. Product ID: B1370-285264. Molecular formula: C26H35N7O5S. Mole weight: 557.67. Custom synthesis is available. Send your inquiries for more information. | London |
| VH 032-linker 6 | VH 032-linker 6 is a von-Hippel-Lindau protein ligand (VHL) conjugated to a PEGylated crosslinker with terminal alkyne for PROTAC technology. It has been used as a degrader building block in PROTAC for targeted protein degradation. Group: Pharmaceutical. Alternative Names: VH032-PEG3-acetylene; (2S,4R)-1-((S)-2-(tert-Butyl)-4-oxo-6,9,12-trioxa-3-azapentadec-14-yn-1-oyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide. CAS No. 2098799-80-3. Pack Sizes: 200 mg. Product ID: B2693-285288. Molecular formula: C31H42N4O7S. Mole weight: 614.75. Custom synthesis is available. Send your inquiries for more information. | London |
| VH-298 | VH-298 is a high-affinity inhibitor of E3 ubiquitin ligase VHL (Kd value of 80-90 nM) that could block VHL and HIF-α interactions. VH-298 can be used in PROTAC technology. Uses: Enzyme inhibitors. Group: Pharmaceutical. Alternative Names: (2S,4R)-1-((S)-2-(1-cyanocyclopropanecarboxamido)-3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide; EX-A1505; VH 298; VH298; VH-298. CAS No. 2097381-85-4. Pack Sizes: 50 mg. Product ID: B2693-170543. Molecular formula: C27H33N5O4S. Mole weight: 523.65. Custom synthesis is available. Send your inquiries for more information. | London |
| 1-Methyl-2-pyrrolidinone SG | 1lt Pack Size. Group: Solvents. Formula: C5H9NO. CAS No. 872-50-4. Prepack ID : 43456401-1lt. Molecular Weight : 99.13. |  |
| 2-(2-hydroxy-4,5-dimethoxybenzamido)thiazole-4-carboxylic acid | An impurity of Acotiamide, a drug for the treatment of postprandial fullness, upper abdominal bloating, and early satiation due to functional dyspepsia. Group: Pharmaceutical. Alternative Names: N-[[1-[(4-aminocyclohexyl)methyl]pyrrolidin-2-yl]methyl]-N-[(E)-3-(2,4-difluorophenyl)-2-methylprop-2-enyl]-3,4-dimethoxybenzamide; tert-butyl N-[4-[[2-[[[(E)-3-(2,4-difluorophenyl)-2-methylprop-2-enyl]-(3,4-dimethoxybenzoyl)amino]methyl]pyrrolidin-1-yl]methyl]cyclohexyl]carbamate. CAS No. 1809272-85-2. Pack Sizes: 100 mg. Product ID: B0228-284900. Molecular formula: C13H12N2O6S. Mole weight: 324.31. Custom synthesis is available. Send your inquiries for more information. | London |
| 2-butoxy-7-[[4-(1-pyrrolidinylmethyl)phenyl]methyl]-5H-pyrrolo[3,2-d]pyrimidin-4-amine | 2-butoxy-7-[[4-(1-pyrrolidinylmethyl)phenyl]methyl]-5H-pyrrolo[3,2-d]pyrimidin-4-amine, a medicinal molecule known for its kinase-inhibiting properties, has been identified as a potential candidate for cancer therapy due to its unique ability to induce apoptosis and inhibit the proliferation of malignant cells. With promising applications in the treatment of leukemia and lung cancer, this small-molecule inhibitor has the potential to address critical unmet clinical needs in cancer management. Its effectiveness and suitability as a therapeutic intervention call for further investigation in the field of oncology. Group: Pharmaceutical. Alternative Names: 5H-Pyrrolo[3,2-d]pyrimidin-4-amine, 2-butoxy-7-[[4-(1-pyrrolidinylmethyl)phenyl]methyl]-. CAS No. 1878111-20-6. Pack Sizes: 5 mg. Product ID: B0001-008679. Molecular formula: C22H29N5O. Mole weight: 379.51. Custom synthesis is available. Send your inquiries for more information. | London |
| (2R,4R)-Teneligliptin | One isomer form of Teneligliptin, which is a DPP-4 inhibitor and has been found to be effective in the treatment of type 2 diabetes. Group: Pharmaceutical. Alternative Names: Teneligliptin (2R,4R)-Isomer; [(2R,4R)-4-[4-(3-Methyl-1-phenyl-1H-pyrazol-5-yl)-1-piperazinyl]-2-pyrrolidinyl]-3-thiazolidinylmethanone. CAS No. 1404559-17-6. Pack Sizes: 10 mg. Product ID: B2694-483037. Molecular formula: C22H30N6OS. Mole weight: 426.59. Custom synthesis is available. Send your inquiries for more information. | London |
| (3R,5S)-5-Biphenyl-4-ylmethyl-3-methylpyrrolidin-2-one | An impurity of Sacubitril, which is an antihypertensive. The combination drug of sacubitril and valsartan is used for heart failure. Group: Pharmaceutical. Alternative Names: 2-Pyrrolidinone, 5-([1,1'-biphenyl]-4-ylMethyl)-3-Methyl-, (3R,5S)-. CAS No. 1038924-70-7. Pack Sizes: 100 mg. Product ID: B1604-479385. Molecular formula: C18H19NO. Mole weight: 265.356. Custom synthesis is available. Send your inquiries for more information. | London |
| 7-Epiclindamycin 2-Phosphate | 7-Epiclindamycin 2-Phosphate is an impurity of Clindamycin, an antibiotic medication used for the treatment of bacterial infections. Group: Pharmaceutical. Alternative Names: 7-Epiclindamycin phosphate; Methyl 7-Chloro-6,7,8-trideoxy-6-[[[(2S,4R)-1-methyl-4-propyl-2-pyrrolidinyl]carbonyl]amino]-1-thio-D-erythro-α-D-galacto-octopyranoside 2-(Dihydrogen Phosphate); Clindamycin Phosphate EP Impurity L. CAS No. 620181-05-7. Pack Sizes: 1 mg. Product ID: B1370-119595. Molecular formula: C18H34ClN2O8PS. Mole weight: 504.96. Custom synthesis is available. Send your inquiries for more information. | London |
| A-395 | A-395 is an antagonist of polycomb repressive complex 2 (PRC2) protein-protein interactions, and can effectively inhibit the trimeric PRC2 complex (EZH2-EED-SUZ12) with an IC50 of 18 nM. Group: Pharmaceutical. Alternative Names: 3-Pyrrolidinamine, 1-(7-fluoro-2,3-dihydro-1H-inden-1-yl)-N,N-dimethyl-4-[4-[4-(methylsulfonyl)-1-piperazinyl]phenyl]-, (3R,4S)-; (3R,4S)-1-(7-Fluoro-2,3-dihydro-1H-inden-1-yl)-N,N-dimethyl-4-{4-[4-(methylsulfonyl)-1-piperazinyl]phenyl}-3-pyrrolidinamine. CAS No. 2089148-72-9. Pack Sizes: 1mg;1g;10g. Product ID: 2089148-72-9. Molecular formula: C26H35FN4O2S. Mole weight: 486.65. Custom synthesis is available. Send your inquiries for more information. | London |
| ABT 089 dihydrochloride | ABT 089 dihydrochloride is a selective α4β2 nicotinic acetylcholine receptor partial agonist (Ki = 16 nM) with >1000-fold and >10,000-fold selectivity for α4β2 over α1β1γ1 and α7 receptors, respectively. ABT 089 dihydrochloride is used as a nootropic and neuroprotective agent. Uses: Nootropic and neuroprotective agent. Group: Pharmaceutical. Alternative Names: ABT 089 dihydrochloride; ABT089 dihydrochloride; ABT-089 dihydrochloride; 2-Methyl-3-[(2S)-pyrrolidinylmethoxy]pyridine dihydrochloride; Pozanicline hydrochloride. CAS No. 161416-61-1. Pack Sizes: 1mg;1g;10g. Product ID: 161416-61-1. Molecular formula: C11H16N2O.2HCl. Mole weight: 265.18. Custom synthesis is available. Send your inquiries for more information. | London |
| ABT279 | ABT279 is a bio-active chemical coumpound. It is used for the treatment of type 2 diabetes. It was developed by Abbvie and was in clinical phase 1 trial, but now it is terminated. Uses: Abt279 is used for the treatment of type 2 diabetes. Group: Pharmaceutical. Alternative Names: ABT-279; ABT 279; 4-Pyridinecarboxylic acid, 2-(4-((2-((2S,5R)-2-cyano-5-ethynyl-1-pyrrolidinyl)-2-oxoethyl)amino)-4-methyl-1-piperidinyl)-. CAS No. 676559-83-4. Pack Sizes: 1mg;1g;10g. Product ID: 676559-83-4. Molecular formula: C21H25N5O3. Mole weight: 395.46. Custom synthesis is available. Send your inquiries for more information. | London |
| ABX-1431 | ABX-1431 is an inhibitor of monoacylglycerol lipase (MAGL; IC50s = 14 and 27 nM for human and rat enzyme, respectively). Group: Pharmaceutical. Alternative Names: 1,1,1,3,3,3-hexafluoropropan-2-yl 4-[[2-pyrrolidin-1-yl-4-(trifluoromethyl)phenyl]methyl]piperazine-1-carboxylate. CAS No. 1446817-84-0. Pack Sizes: 1mg;1g;10g. Product ID: 1446817-84-0. Molecular formula: C20H22F9N3O2. Mole weight: 507.3. Custom synthesis is available. Send your inquiries for more information. | London |
| Aglain C | Aglain C, an organic alkaloid of natural origins, demonstrates anti-tumor activity, thus possessing potential application in diverse cancer treatment modalities. It elicits apoptosis, or cell death, in malignant cells, and exhibits anti-inflammatory properties. To ascertain its therapeutic value comprehensively, additional examination is warranted. Group: Pharmaceutical. Alternative Names: N-((S)-1-((2R,3S,4R,5R,10S)-5,10-dihydroxy-6,8-dimethoxy-2-(4-methoxyphenyl)-3-phenyl-2,3,4,5-tetrahydro-2,5-methanobenzo[b]oxepine-4-carbonyl)pyrrolidin-2-yl)-2-methylbutanamide. CAS No. 177468-85-8. Pack Sizes: 2 mg. Product ID: NP0163. Molecular formula: C36H42N2O8. Mole weight: 630.727. Custom synthesis is available. Send your inquiries for more information. | London |
| Aglaxiflorin D | Aglaxiflorin D is an alkaloid compound isolated from the leaves of Aglaia abbriviata. Group: Pharmaceutical. Alternative Names: (R)-N-((S)-1-((2R,3S,4R,5R,10S)-5,10-dihydroxy-6,8-dimethoxy-2-(4-methoxyphenyl)-3-phenyl-2,3,4,5-tetrahydro-2,5-methanobenzo[b]oxepine-4-carbonyl)pyrrolidin-2-yl)-2-hydroxy-2-methylbutanamide. CAS No. 269739-78-8. Pack Sizes: 2 mg. Product ID: NP0201. Molecular formula: C36H42N2O9. Mole weight: 646.727. Custom synthesis is available. Send your inquiries for more information. | London |
| Alizapride hydrochloride | Alizapride is a dopamine antagonist with prokinetic and antiemetic effects used in the treatment of nausea and vomiting, including postoperative nausea and vomiting. Group: Pharmaceutical. Alternative Names: 6-Methoxy-N-[[1-(2-propenyl)-2-pyrrolidinyl]methyl]-1H-benzotriazole-5-carboxamide Hydrochloride; Limican; Nausilen; Plitican; Vergentan; N-[(1-Allyl-2-pyrrolidinyl)methyl]-5-methoxy-1H-benzotriazole-6-carboxamide hydrochloride (1:1). CAS No. 59338-87-3. Pack Sizes: 200 mg. Product ID: B0084-095175. Molecular formula: C16H22ClN5O2. Mole weight: 351.83. Custom synthesis is available. Send your inquiries for more information. | London |
| Anticefepime | Anticefepime is an impurity of Cefepime, an fourth generation cephalosporin antibiotic. Group: Pharmaceutical. Alternative Names: Cefepime Impurity A; (6R,7R)-7-[[(2E)-(2-Aminothiazol-4-yl)(methoxyimino)acetyl]amino]-3-[(1-methylpyrrolidinio)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate; Cefepime EP Impurity A; Anti-cefepime; E-Cefepime; (E)-Cefepime; 1-[[(6R,7R)-7-[[(2E)-2-(2-Amino-4-thiazolyl)-2-(methoxyimino)acetyl]amino]-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl]-1-methyl-pyrrolidinium inner salt; Pyrrolidinium, 1-[[(6R,7R)-7-[[(2E)-2-(2-amino-4-thiazolyl)-2-(methoxyimino)acetyl]amino]-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl]-1-methyl-, inner salt; Pyrrolidinium, 1-[[7-[[(2-amino-4-thiazolyl)(methoxyimino)acetyl]amino]-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl]-1-methyl-, inner salt, [6R-[6α,7β(E)]]-; Cefepime dihydrochloride monohydrate EP Impurity A. CAS No. 97164-57-3. Pack Sizes: 25 mg. Product ID: B1370-153673. Molecular formula: C19H24N6O5S2. Mole weight: 480.57. Custom synthesis is available. Send your inquiries for more information. | London |
| Barnidipine-[d5] | Barnidipine-[d5] is a stable isotope form of Barnidipine which is a calcium channel blocker. Group: Pharmaceutical. Alternative Names: 3-(3S)-1-[(D5)benzyl]pyrrolidin-3-yl 5-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate; (S)-3-((S)-1-Benzylpyrrolidin-3-yl) 5-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate-d5. Pack Sizes: 5 mg. Product ID: BLP-003392. Molecular formula: C27H24D5N3O6. Mole weight: 496.57. Custom synthesis is available. Send your inquiries for more information. | London |
| BIO 5192 | BIO 5192 is a selective and potent inhibitor of integrin α4β1 (Very Late Antigen-4; VLA-4) (Kd < 10 pM) with selectivity for α4β1 over a range of other integrins (IC50 values are 1.8, 138, 1053,> 500 and > 10,000 nM for α4β1, α9β1, α2β1, α4β7 and αIIbβ3, respectively). BIO 5192 causes a 30-fold increase in mobilization of murine hematopoietic stem and progenitors (HSPCs) over basal levels. Group: Pharmaceutical. Alternative Names: BIO-5192; AMD-15057; BIO 5192; AMD 15057; BIO5192; AMD15057; (2S)-2-[[[(2S)-1-[(3,5-Dichlorophenyl)sulfonyl]-2-pyrrolidinyl]carbonyl]amino]-4-[[(2S)-4-methyl-2-[methyl[2-[4-[[[(2-methylphenyl)amino]carbonyl]amino]phenyl]acetyl]amino]-1-oxopentyl]amino]butanoic acid. CAS No. 327613-57-0. Pack Sizes: 10 mg. Product ID: B2693-119144. Molecular formula: C38H46Cl2N6O8S. Mole weight: 817.78. Custom synthesis is available. Send your inquiries for more information. | London |
| Cediranib maleate | Cediranib maleate is a highly potent VEGFR(KDR) inhibitor with IC50 of <1 nM. It also inhibits Flt1/4 with IC50 of 5 nM/≤3 nM. It inhibits VEGF-stimulated proliferation with IC50 of 0.4 nM in vitro. It suppresses PDGF-AA with IC50 of 0.04 μM in MG63 cell lines. It even suppresses tubule sprouting at subnanomolar concentrations and inhibits VEGF-induced angiogenesis in vivo. It causes hypertrophy in bone growth plate and prevents luteal development in ovary. It shows broad spectrum activity in human tumor models at doses that are well tolerated. It causes regression of vascular tissues in human lung tumor xenografts. Group: Pharmaceutical. Alternative Names: AZD 2171 maleate; Recentin; 4-[(4-fluoro-2-methyl-1H-indol-5-yl)oxy]-6-methoxy-7-(3-pyrrolidin-1-ylpropoxy)quinazoline maleate. CAS No. 857036-77-2. Pack Sizes: 100 mg. Product ID: B2693-459903. Molecular formula: C29H31FN4O7. Mole weight: 566.6. Custom synthesis is available. Send your inquiries for more information. | London |
| Cefepime Hydrochloride | It is an anti-bacterial drug and a non-competitive inhibitor. It is a semi-synthetic, fourth generation cephalosporin antibiotic. Uses: Anti-bacterial agents. Group: Pharmaceutical. Alternative Names: Cefepime dihydrochloride; Cepimex; Axepim; Cepimax; Cefepime HCl; BMY 28142 Hydrochloride; Maxcef; Maxipime; Novapime; [6R-[6α,7β(Z)]]-1-[[7-[[(2-Amino-4-thiazolyl)(methoxyimino)acetyl]amino]-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl]-1-methyl-pyrrolidinium hydrochloride; Pyrrolidinium, 1-[[(6R,7R)-7-[[(2Z)-2-(2-amino-4-thiazolyl)-2-(methoxyimino)acetyl]amino]-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl]-1-methyl-, chloride, hydrochloride (1:1:1); Pyrrolidinium, 1-[[(6R,7R)-7-[[(2Z)-(2-amino-4-thiazolyl)(methoxyimino)acetyl]amino]-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl]-1-methyl-, chloride, monohydrochloride; Pyrrolidinium, 1-[[7-[[(2-amino-4-thiazolyl)(methoxyimino)acetyl]amino]-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl]-1-methyl-, chloride, monohydrochloride, [6R-[6α,7β(Z)]]-. CAS No. 107648-80-6. Pack Sizes: 1mg;1g;10g. Product ID: BBF-04630. Molecular formula: C19H26Cl2N6O5S2. Mole weight: 553.48. Custom synthesis is available. Send your inquiries for more information. | London |
| Cefepime Related Compound E | An impurity of Cefepime. Cefepime is a fourth-generation cephalosporin antibiotic known for its broad-spectrum activity against a wide range of Gram-positive and Gram-negative bacteria. It is particularly effective against many organisms that are resistant to other antibiotics, including some beta-lactamase-producing strains. Cefepime is often used to treat severe infections such as pneumonia, urinary tract infections, and bloodstream infections. Group: Pharmaceutical. Alternative Names: 1-{[(6R,7R)-7-Amino-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl}-1-methylpyrrolidin-1-ium chloride; 7-Amino-3-[(1-methylpyrrolidin-1-ium-1-yl)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate hydrochloride; Pyrrolidinium, 1-[[(6R,7R)-7-amino-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl]-1-methyl-, chloride; Pyrrolidinium, 1-[(7-amino-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl)methyl]-1-methyl-, hydroxide, inner salt, monohydrochloride, (6R-trans)-; USP Cefepime Related Compound E; Cefepime USP Related Compound E; Cefepime amine derivative; (6R,7R)-7-Amino-3-[(1-methylpyrrolidinium-1-yl)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate chloride. CAS No. 103121-85-3. Pack Sizes: 25 mg. Product ID: B0552-286040. Molecular formula: C13H20ClN3O3S. Mole weight: 333.83. Custom synthesis is available. Send your inquiries for more information. | London |
| Cefiderocol | This active molecular is a potent cephalosporin antibiotic with a catechol moiety on the 3-position side chain under the development of Shionogi. Cefiderocol exhibits potent activity against the non-fermenting Gram-negative bacteria in vitro including Acinetobacter baumannii, Pseudomonas aeruginosa and Stenotrophomonas maltophilia. Now Cefiderocol is in clinical Phase III for treatment of severe infections caused by Carbapenem-resistant Gram-negative pathogens. Uses: Gram-negative infections. Group: Pharmaceutical. Alternative Names: S-649266; S 649266; S649266; Cefiderocol; (6R,7R)-7-[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-{[(2-carboxypropan-2-yl)oxy]imino}acetamido]-3-({1-[2-(2-chloro-3,4-dihydroxybenzamido)ethyl]pyrrolidin-1-ium-1-yl}methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate;S649266. CAS No. 1225208-94-5. Pack Sizes: 1 mg. Product ID: B0084-475177. Molecular formula: C30H34ClN7O10S2. Mole weight: 752.22. Custom synthesis is available. Send your inquiries for more information. | London |
| Ceftobiprole | Ceftobiprole is a cephalosporin prodrug with potent bactericidal activity against methicillin-resistant MRSA and penicillin-resistant Streptococcus pneumoniae (PRSP). Group: Pharmaceutical. Alternative Names: (6R,7R)-7-[[(2Z)-2-(5-amino-1,2,4-thiadiazol-3-ylidene)-2-nitrosoacetyl]amino]-8-oxo-3-[(E)-[2-oxo-1-[(3R)-pyrrolidin-3-yl]pyrrolidin-3-ylidene]methyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; BAL 9141; BAL9141. CAS No. 209467-52-7. Pack Sizes: 5 mg. Product ID: B2692-062749. Molecular formula: C20H22N8O6S2. Mole weight: 534.57. Custom synthesis is available. Send your inquiries for more information. | London |
| Cipropride S enantiomer | Cipropride S enantiomer is the S enantiomer of cipropride which is an antiemetic drug. Group: Pharmaceutical. Alternative Names: N-[[(2S)-1-(cyclopropylmethyl)pyrrolidin-2-yl]methyl]-2-methoxy-5-sulfamoylbenzamide; Cipropride (S enantiomer). CAS No. 66183-70-8. Pack Sizes: 1mg;1g;10g. Product ID: 66183-70-8. Molecular formula: C17H25N3O4S. Mole weight: 367.46. Custom synthesis is available. Send your inquiries for more information. | London |
| Clemizole hydrochloride | The hydrochloride salt form of clemizole, which is a histamine H1 antagonist with antitumor activity. It also has hepatitis C antiviral effect through restraining NS4B function and could also be used as an anticonvulsant in zebrafish Dravet syndrome model. Group: Pharmaceutical. Alternative Names: Allercur; Clemizole HCl; Clemizole (hydrochloride); Reactrol; 1-[(4-chlorophenyl)methyl]-2-(pyrrolidin-1-ylmethyl)benzimidazole hydrochloride. CAS No. 1163-36-6. Pack Sizes: 100 mg. Product ID: B0084-055145. Molecular formula: C19H20ClN3.HCl. Mole weight: 362.3. Custom synthesis is available. Send your inquiries for more information. | London |
| Clindamycin Hydrochloride | Clindamycin hydrochloride is the hydrochloride salt of Clindamycin, which is a semisynthetic antibiotic prepared from Lincomycin. Group: Pharmaceutical. Alternative Names: (2S-trans)-Methyl 7-Chloro-6,7,8-trideoxy-6-[[[(2S,4R)-1-methyl-4-propyl-2-pyrrolidinyl]carbonyl]amino]-1-thio-L-threo-α-D-galactooctopyranoside Hydrochloride; 7(S)-Chloro-7-deoxylincomycin; 7-CDL; 7-Chloro-7-deoxylincomycin; 7-Chlorolincomycin; Antirobe; Chlolincocin; Cleocin; Clinimycin; Dalacine; Clindamycin Phosphate EP Impurity E. CAS No. 21462-39-5. Pack Sizes: 50 g. Product ID: B2693-300287. Molecular formula: C18H34Cl2N2O5S. Mole weight: 461.44. Custom synthesis is available. Send your inquiries for more information. | London |
| Daclatasvir dihydrochloride | Daclatasvir is a highly selective inhibitor of HCV NS5A with EC50 of 9-50 pM, for a broad range of HCV replicon genotypes and the JFH-1 genotype 2a infectious virus in cell culture. Group: Pharmaceutical. Alternative Names: Methyl N-[(2S)-1-[(2S)-2-[5-[4-[4-[2-[(2S)-1-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidin-2-yl]-1H-imidazol-5-yl]phenyl]phenyl]-1H-imidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate dihydrochloride; Daclatasvir; BMS790052; BMS 790052; BMS-790052; EBP883; EBP 883; EBP-883; Daklinza. CAS No. 1009119-65-6. Pack Sizes: 5 g. Product ID: B0084-454273. Molecular formula: C40H50N8O6·2HCl. Mole weight: 811.8. Custom synthesis is available. Send your inquiries for more information. | London |
| Δ2-Cefepime | An impurity of Cefepime, a cephalosporin antibiotic against Gram-positive and Gram-negative bacteria. Group: Pharmaceutical. Alternative Names: Pyrrolidinium, 1- [[(6R, 7R) - 7- [[(2Z) - 2- (2- amino- 4- thiazolyl) - 2- (methoxyimino) acetyl] amino] - 2- carboxy- 8- oxo- 5- thia- 1- azabicyclo[4.2.0] oct- 3- en- 3- yl] methyl] - 1- methyl- , inner salt; Delta2-Cefepime. CAS No. 88040-25-9. Pack Sizes: 100 mg. Product ID: B1370-468398. Molecular formula: C19H24N6O5S2. Mole weight: 480.57. Custom synthesis is available. Send your inquiries for more information. | London |
| Diroximel Fumarate | Diroximel Fumarate is a prodrug of monomethyl fumarate in a controlled-release formulation that rapidly and efficiently converts to MMF in the body. It reduces the progressive damage to nerve cells via activating the Nrf2 pathway. It also acts as a NF-kappa B inhibitor. Group: Pharmaceutical. Alternative Names: ALKS8700; ALKS 8700; ALKS-8700; 2-(2,5-Dioxopyrrolidin-1-yl)ethyl methyl fumarate; 1-[2-(2,5-Dioxo-1-pyrrolidinyl)ethyl] 4-methyl (2E)-2-butenedioate; 2-Butenedioic acid (2E)-, 1-[2-(2,5-dioxo-1-pyrrolidinyl)ethyl] 4-methyl ester. CAS No. 1577222-14-0. Pack Sizes: 100 mg. Product ID: B0084-284754. Molecular formula: C11H13NO6. Mole weight: 255.22. Custom synthesis is available. Send your inquiries for more information. | London |
| DM1-SPP | DM1 with a reactive linker SPP, which can react with antibody to make antibody drug conjugate, as a potent EGFR inhibitor and it overcomes resistant to EGFR. Group: Pharmaceutical. Alternative Names: N2'-deacetyl-N2'-[3-[[4-[(2,?5-dioxo-1-pyrrolidinyl)?oxy]?-1-methyl-4-oxobutyl]?dithio]?-1-oxopropyl]?-Maytansine; DM1 SPP. CAS No. 452072-20-7. Pack Sizes: 5 mg. Product ID: BADC-00010. Molecular formula: C44H59ClN4O14S2. Mole weight: 967.54. Custom synthesis is available. Send your inquiries for more information. | London |
| DM4-SPDB | DM4 with a reactive linker SPDB, which can react with antibody to make antibody drug conjugate. DM4 can bind to tubulin at or near the vinblastine-binding site. Group: Pharmaceutical. Alternative Names: (1S,2R,3S,5S,6S,16E,18E,20R,21S)-11-Chloro-21-hydroxy-12,20-dimethoxy-2,5,9,16-tetramethyl-8,23-dioxo-4,24-dioxa-9,22-diazatetracyclo[19.3.1.110,14.03,5]hexacosa-10(26),11,13,16,18-pentaen-6-yl (2 S)-2-{[4-({4-[(2,5-dioxo-1-pyrrolidinyl)oxy]-4-oxobutyl}disulfanyl)-4-methylpentanoyl](methyl)amino}propanoate (non-preferred name); DM4 SPDB. CAS No. 1626359-62-3. Pack Sizes: 1 mg. Product ID: BADC-00012. Molecular formula: C46H63ClN4O14S2. Mole weight: 995.59. Custom synthesis is available. Send your inquiries for more information. | London |
| Dolastatin 10 | Dolastatin 10 is a potent antimitotic peptide from a marine animal, strongly inhibiting microtubule assembly. Uses: Adcs cytotoxin. Group: Pharmaceutical. Alternative Names: DLS 10; NSC 376128; Dolastatin-10; DLS-10; DLS10; NSC376128; NSC-376128; L-Valinamide, N,N-dimethyl-L-valyl-N-[2-methoxy-4-[2-[1-methoxy-2-methyl-3-oxo-3-[[2-phenyl-1-(2-thiazolyl)ethyl]amino]propyl]-1-pyrrolidinyl]-1-(1-methylpropyl)-4-oxobutyl]-N-methyl-,[2S-[1[1R*(R*),2S*],2R*[1S*,2S*,3(R*)]]]-. CAS No. 110417-88-4. Pack Sizes: 5 mg. Product ID: BAT-010469. Molecular formula: C42H68N6O6S. Mole weight: 785.09. Custom synthesis is available. Send your inquiries for more information. | London |
| Fitusiran | Fitusiran, a small interfering RNA, specifically targets antithrombin (AT) messenger RNA to lower production of AT in the liver. It increases thrombin generation and has the potential for the research of the hemophilia. Group: Pharmaceutical. Alternative Names: ALN-AT3SC; SAR439774; RNA, ((2'-deoxy-2'-fluoro)G-sp-Gm-sp-(2'-deoxy-2'-fluoro)U-Um-(2'-deoxy-2'-fluoro)A-Am-(2'-deoxy-2'-fluoro)C-Am-(2'-deoxy-2'-fluoro)C-(2'-deoxy-2'-fluoro)C-(2'-deoxy-2'-fluoro)A-Um-(2'-deoxy-2'-fluoro)U-Um-(2'-deoxy-2'-fluoro)A-Cm-(2'-deoxy-2'-fluoro)U-Um-(2'-deoxy-2'-fluoro)C-Am-(2'-deoxy-2'-fluoro)A),3'-[[(2S,4R)-1-[29-[[2-(acetylamino)-2-deoxy-β-D-galactopyranosyl]oxy]-14,14-bis[[3-[[3-[[5-[[2-(acetylamino)-2-deoxy-β-Dgalactopyranosyl]oxy]-1-oxopentyl]amino]propyl]amino]-3-oxopropoxy]methyl]-1,12,19,25-tetraoxo-16-oxa-13,20,24-triazanonacos-1-yl]-4-hydroxy-2-pyrrolidinyl]methyl hydrogen phosphate], complex with RNA (Um-sp-(2'-deoxy-2'-fluoro)U-sp-Gm-(2'-deoxy2'-fluoro)A-Am-(2'-deoxy-2'-fluoro)G-Um-(2'-deoxy-2'-fluoro)A-Am-(2'-deoxy-2'-fluoro)A-Um-Gm-Gm-(2'-deoxy-2'-fluoro)U-Gm-(2'-deoxy-2'-fluoro)U-Um-(2'-deoxy-2'-fluoro)A-Am-(2'-deoxy-2'-fluoro)C-Cm-sp-Am-sp-Gm). CAS No. 1499251-18-1. Pack Sizes: 1 mg. Product ID: B1370-072729. Custom synthesis is available. Send your inquiries for more information. | London |
| GalNac-L96 free base | GalNAC-L96 free base is a triantennary GalNAc ligand that can be used for the synthesis of GalNAC-SiRNA and for the delivery of nucleic acid drugs. GalNAc is a ligand for the asialal glycoprotein receptor (ASGPR). Group: Pharmaceutical. Alternative Names: L-96; Butanedioic acid, 1-[(3R,5S)-5-[[bis(4-methoxyphenyl)phenylmethoxy]methyl]-1-[1,12,19,25-tetraoxo-14,14-bis[[3-oxo-3-[[3-[[1-oxo-5-[[3,4,6-tri-O-acetyl-2-(acetylamino)-2-deoxy-β-D-galactopyranosyl]oxy]pentyl]amino]propyl]amino]propoxy]methyl]-29-[[3,4,6-tri-O-acetyl-2-(acetylamino)-2-deoxy-β-D-galactopyranosyl]oxy]-16-oxa-13,20,24-triazanonacos-1-yl]-3-pyrrolidinyl] ester; 1-[(3R,5S)-5-[[Bis(4-methoxyphenyl)phenylmethoxy]methyl]-1-[1,12,19,25-tetraoxo-14,14-bis[[3-oxo-3-[[3-[[1-oxo-5-[[3,4,6-tri-O-acetyl-2-(acetylamino)-2-deoxy-β-D-galactopyranosyl]oxy]pentyl]amino]propyl]amino]propoxy]methyl]-29-[[3,4,6-tri-O-acetyl-2-(acetylamino)-2-deoxy-β-D-galactopyranosyl]oxy]-16-oxa-13,20,24-triazanonacos-1-yl]-3-pyrrolidinyl] butanedioate; GalNAc-L96-SA; L-96-Succinic Acid; GalNAc-L96-Succinate. CAS No. 1159408-61-3. Pack Sizes: 100 mg. Product ID: B1370-427872. Molecular formula: C121H179N11O45. Mole weight: 2507.76. Custom synthesis is available. Send your inquiries for more information. | London |
| Givosiran sodium | Givosiran sodium is a small interfering RNA (siRNA) directed towards delta-aminolevulinate synthase 1 (ALAS1). Givosiran sodium has been indicated for the treatment of adults with acute hepatic porphyria (AHP). Group: Pharmaceutical. Alternative Names: ALN-AS1 sodium; ALN AS1 sodium; ALN-AS 1 sodium; WHO 10280 sodium; WHO-10280 sodium; WHO10280 sodium; Givlaari sodium; RNA, (Cm-sp-Am-sp-Gm-Am-Am-Am-(2'-deoxy-2'-fluoro)G-Am-(2'-deoxy-2'-fluoro)G-Um-(2'-deoxy-2'-fluoro)G-Um-(2'-deoxy-2'-fluoro)C-Um-(2'-deoxy-2'-fluoro)C-Am-Um-Cm-Um-Um-Am), 3'-[[(2S,4R)-1-[29-[[2-(acetylamino)-2-deoxy-β-D-galactopyranosyl]oxy]-14,14-bis[[3-[[3-[[5-[[2-(acetylamino)-2-deoxy-β-D-galactopyranosyl]oxy]-1-oxopentyl]amino]propyl]amino]-3-oxopropoxy]methyl]-1,12,19,25-tetraoxo-16-oxa-13,20,24-triazanonacos-1-yl]-4-hydroxy-2-pyrrolidinyl]methyl hydrogen phosphate], complex with RNA (Um-sp-(2'-deoxy-2'-fluoro)A-sp-(2'-deoxy-2'-fluoro)A-(2'-deoxy-2'-fluoro)G-Am-(2'-deoxy-2'-fluoro)U-Gm-(2'-deoxy-2'-fluoro)A-Gm-(2'-deoxy-2'-fluoro)A-Cm-(2'-deoxy-2'-fluoro)A-Cm-(2'-deoxy-2'-fluoro)U-Cm-(2'-deoxy-2'-fluoro)U-Um-(2'-deoxy-2'-fluoro)U-Cm-(2'-deoxy-2'-fluoro)U-Gm-sp-Gm-sp-Um) (1:1) sodium salt. Pack Sizes: 10 mg. Product ID: B1370-212888. Molecular formula: C524H651F16N173Na43O316P43S6. Mole weight: 17,245.56 Da. Custom synthesis is available. Send your inquiries for more information. | London |
| Inclisiran | Inclisiran is a medication approved for the treatment of people with atherosclerotic cardiovascular disease (ASCVD), ASCVD risk equivalents and heterozygous familial hypercholesterolemia (HeFH). It is a small interfering RNA (siRNA) that binds to PCSK9 messenger RNA, resulting in decreased concentrations of PCSK9 and plasma concentrations of LDL cholesterol. Group: Pharmaceutical. Alternative Names: ALN-PCSsc; ALN-60212; Leqvio; Inclisiran sodium; ALN-PCS; Leqvio; RNA, (Am-sp-(2'-deoxy-2'-fluoro)C-sp-Am-(2'-deoxy-2'-fluoro)A-(2'-deoxy-2'-fluoro)A-(2'-deoxy-2'-fluoro)A-Gm-(2'-deoxy-2'-fluoro)C-Am-(2'-deoxy-2'-fluoro)A-Am-(2'-deoxy-2'-fluoro)A-Cm-(2'-deoxy-2'-fluoro)A-Gm-(2'-deoxy-2'-fluoro)G-Um-(2'-deoxy-2'-fluoro)C-Um-Am-Gm-sp-Am-sp-Am), complex with RNA (Cm-sp-Um-sp-Am-Gm-Am-Cm-(2'-deoxy-2'-fluoro)C-Um-(2'-deoxy-2'-fluoro)G-Um-dT-Um-Um-Gm-Cm-Um-Um-Um-Um-Gm-Um) 3'-[[(2S,4R)-1-[29-[[2-(acetylamino)-2-deoxy-β-D-galactopyranosyl]oxy]-14,14-bis[[3-[[3-[[5-[[2-(acetylamino)-2-deoxy-β-D-galactopyranosyl]oxy]-1-oxopentyl]amino]propyl]amino]-3-oxopropoxy]methyl]-1,12,19,25-tetraoxo-16-oxa-13,20,24-triazanonacos-1-yl]-4-hydroxy-2-pyrrolidinyl]methyl hydrogen phosphate] (1:1). CAS No. 1639324-58-5. Pack Sizes: 5 mg. Product ID: B1370-057828. Molecular formula: C529H707F12N176O316P43S6. Mole weight: 16339.48. Custom synthesis is available. Send your inquiries for more information. | London |
| Lincomycin | It is produced by the strain of Str. lincolnensis var. lincolnensis NRRL 2936. It's a sugar antibiotic. It has anti-gram-positive bacteria and spirochete effect, and has weak antibacterial effect on some gram-negative bacteria. It can protect mice infected with Staphylococcus aureus, Streptococcus hemolyticus and dicoccus pneumoniae by oral or subcutaneous injection. It also has effect on leptospira in vivo. Uses: Anti-bacterial agents. Group: Pharmaceutical. Alternative Names: (2S-trans)-Methyl 6,8-Dideoxy-6-[[(1-methyl-4-propyl-2-pyrrolidinyl)carbonyl]amino]-1-thio-D-erythro-α-D-galacto-octopyranoside; Lincocin; Lincogap; Clindamycin Phosphate EP Impurity A; Clindamycin hydrochloride EP Impurity A. CAS No. 154-21-2. Pack Sizes: 1mg;1g;10g. Product ID: BBF-02652. Molecular formula: C18H34N2O6S. Mole weight: 406.54. Custom synthesis is available. Send your inquiries for more information. | London |
| Lincomycin 2-Phosphate | Lincomycin 2-Phosphate (Clindamycin Phosphate EP Impurity F) is an impurity of Clindamycin, which is a semi-synthetic antibiotic prepared from Lincomycin. Group: Pharmaceutical. Alternative Names: Lincomycin phosphate; Methyl 6,8-dideoxy-6-[[[(2S,4R)-1-methyl-4-propyl-2-pyrrolidinyl]carbonyl]amino]-1-thio-D-erythro-α-D-galacto-Octopyranoside 2-(dihydrogen phosphate); Clindamycin Phosphate EP Impurity F. CAS No. 27480-30-4. Pack Sizes: 5 mg. Product ID: B2694-337341. Molecular formula: C18H35N2O9PS. Mole weight: 486.52. Custom synthesis is available. Send your inquiries for more information. | London |
| Lumasiran | Lumasiran is a siRNA product that reduces hepatic oxalate production by targeting glycolate oxidase. By silencing the gene encoding glycolate oxidase, Lumasiran depletes glycolate oxidase and thereby inhibits the synthesis of oxalate, which is the toxic metabolite that is directly associated with the clinical manifestations of Primary hyperoxaluria type 1 (PH1). Group: Pharmaceutical. Alternative Names: ALN-G01; RNA, (Gm-sp-Am-sp-Cm-Um-Um-Um-(2'-deoxy-2'-fluoro)C-Am-(2'-deoxy-2'-fluoro)U-(2'-deoxy-2'-fluoro)C-(2'-deoxy-2'-fluoro)C-Um-Gm-Gm-Am-Am-Am-Um-Am-Um-Am), 3'-[[(2S,4R)-1-[29-[[2-(acetylamino)-2-deoxy-β-D-galactopyranosyl]oxy]-14,14-bis[[3-[[3-[[5-[[2-(acetylamino)-2-deoxy-β-D-galactopyranosyl]oxy]-1-oxopentyl]amino]propyl]amino]-3-oxopropoxy]methyl]-1,12,19,25-tetraoxo-16-oxa-13,20,24-triazanonacos-1-yl]-4-hydroxy-2-pyrrolidinyl]methyl hydrogen phosphate], complex with RNA (Um-sp-(2'-deoxy-2'-fluoro)A-sp-Um-Am-Um-(2'-deoxy-2'-fluoro)U-Um-(2'-deoxy-2'-fluoro)C-(2'-deoxy-2'-fluoro)C-Am-Gm-Gm-Am-(2'-deoxy-2'-fluoro)U-Gm-(2'-deoxy-2'-fluoro)A-Am-Am-Gm-Um-Cm-sp-Cm-sp-Am) (1:1). CAS No. 1834610-13-7. Pack Sizes: 5 mg. Product ID: B1370-072716. Molecular formula: C530H712F10N173O320P43S6. Mole weight: 16,340 Da. Custom synthesis is available. Send your inquiries for more information. | London |
| LY-2456302 | LY-2456302, also called as CERC-501, is a potent, highly selective and centrally-penetrant kappa opioid receptor antagonist (Ki = 0.807 nM) with favorable pharmacokinetic and pharmacodynamic properties to evaluate the role of KOR in preclinical models of alcoholism. Group: Pharmaceutical. Alternative Names: 4-[4-[[(2S)-2-(3,5-dimethylphenyl)pyrrolidin-1-yl]methyl]phenoxy]-3-fluorobenzamide; 3-fluoro4-(4-((2-(3,5-dimethylphenyl)pyrrolidin-1-yl)methyl)phenoxy)benzamide; LY2456302; CERC-501; LY 2456302; CERC 501; LY-2456302; CERC501. CAS No. 1174130-61-0. Pack Sizes: 100 mg. Product ID: B2693-007347. Molecular formula: C26H27FN2O2. Mole weight: 418.5. Custom synthesis is available. Send your inquiries for more information. | London |
| Mc-MMAE | Mc-MMAE is a protective group conjugated MMAE, MMAE inhibits tubulin polymerization so that it inhibits cell division. Group: Pharmaceutical. Alternative Names: Maleimidocaproyl-monomethylauristatin E; N-[6-(2,5-Dioxo-2,5-dihydro-1H-pyrrol-1-yl)hexanoyl]-N-methyl-L-valyl-N-[(3R,4S,5S)-1-{(2S)-2-[(1R,2R)-3-{[(1S,2R)-1-hydroxy-1-phenyl-2-propanyl]amino}-1-methoxy-2-methyl-3-oxopropyl]-1-pyrrolidinyl}- 3-methoxy-5-methyl-1-oxo-4-heptanyl]-N-methyl-L-valinamide. CAS No. 863971-24-8. Pack Sizes: 1 mg. Product ID: BADC-00025. Molecular formula: C49H78N6O10. Mole weight: 911.18. Custom synthesis is available. Send your inquiries for more information. | London |
| Mc-MMAF | Mc-MMAF is a protective group-conjugated MMAF, MMAF is an antitubulin agent that inhibit cell division by blocking the polymerization of tubulin and it has lower cytotoxic activity than MMAE. Uses: Sgd 1269 is a potent tubulin inhibitor and is a toxin payload in antibody drug conjugate. it is a useful agent for make antibody drug conjugate (adc) for targeted drug delivery. Group: Pharmaceutical. Alternative Names: SGD-1269; SGD 1269; SGD1269; mc-MMAF; mcMMAF; L4-MMAF; Maleimidocaproyl-MMAF; Maleimidocaproyl monomethylauristatin F; Mafodotin.((2R,3R)-3-((S)-1-((3R,4S,5S)-4-((S)-2-((S)-2-(6-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-N-methylhexanamido)-3-methylbutanamido)-N,3-dimethylbutanamido)-3-methoxy-5-methylheptanoyl)pyrrolidin-2-yl)-3-methoxy-2-methylpropanoyl)-L-phenylalanine. CAS No. 863971-19-1. Pack Sizes: 1 mg. Product ID: BADC-00014. Molecular formula: C49H76N6O11. Mole weight: 925.18. Custom synthesis is available. Send your inquiries for more information. | London |
| Meropenem EP Impurity B | Meropenem EP Impurity B is an impurity of Meropenem. Meropenem is a broad-spectrum β-lactam, which is used in complicated intra-abdominal infections. Group: Pharmaceutical. Alternative Names: Meropenem Dimer; 4-Methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic Acid, (4R,5S,6S)-3-(((3S,5S)-1-((2S,3R)-2-((2S,3R)-5-Carboxy-4-(((3S,5S)-5-(Dimethylcarbamoyl)pyrrolidin-3-yl)thio)-3-methyl-2,3-dihydro-1H-pyrrol-2-yl)-3-hydroxybutanoyl)-5-(dimethylcarbamoyl)pyrrolidin-3-yl)thio)-6-((R)-1-hydroxyethyl)-. CAS No. 166901-45-7. Pack Sizes: 10 mg. Product ID: B1370-183396. Molecular formula: C34H50N6O10S2. Mole weight: 766.92. Custom synthesis is available. Send your inquiries for more information. | London |
| Meropenem Trihydrate | Meropenem Trihydrate is a carbapenem antibiotic, which has broad spectrum antibacterial activity. Group: Pharmaceutical. Alternative Names: [4R-[3(3S*,5S*),4α,5β,6β(R*)]]-3-[[5-[(Dimethylamino)carbonyl]-3-pyrrolidinyl]thio]-6-(1-hydroxyethyl)-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic Acid Trihydrate; (4R,5S,6S)-3-[[(3S,5S)-5-[(Dimethylamino)carbonyl]-3-pyrrolidinyl]thio]-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic Acid Trihydrate; SM-7338. CAS No. 119478-56-7. Pack Sizes: 100 mg. Product ID: BBF-04632. Molecular formula: C17H25N3O5S.3H2O. Mole weight: 437.51. Custom synthesis is available. Send your inquiries for more information. | London |
| Mertansine | Mertansine, the cytotoxic component in antibody-drug conjugates, is attached to a monoclonal antibody through reaction of the thiol group with the SPP (N-succinimidyl 4-(2-pyridyldithio)) linker or SMCC (4-(3-mercapto-2,5-dioxo-1 pyrrolidinylmethyl)-cylohexanecarboxylic acid) linkerto create an antibody-drug conjugate. It derives from a maytansine. Group: Pharmaceutical. Alternative Names: (14S,16S,33S,2R,4R,10E,12Z,14R)-86-chloro-14-hydroxy-85,14-dimethoxy-33,2,7,10-tetramethyl-12,6-dioxo-7-aza-1(6,4)-oxazinana-3(2,3)-oxirana-8(1,3)-benzenacyclotetradecaphane-10,12-dien-4-yl N-(3-mercaptopropanoyl)-N-methyl-L-alaninate; N2'-deacetyl-N2'-(3-mercapto-1-oxopropyl)-maytansine; DM 1; Maytansinoid DM 1; N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine; DM-1; DM1; DM1 Compound; DM1 [Maytansinoid]. CAS No. 139504-50-0. Pack Sizes: 40 mg(95%+). Product ID: BBF-05777. Molecular formula: C35H48ClN3O10S. Mole weight: 738.29. Custom synthesis is available. Send your inquiries for more information. | London |
| MMAE | Monomethyl Auristatin E (MMAE) is a synthetic analog of dolastatin 10 that similarly inhibits tubulin polymerization and exhibits potent cytotoxicity. It is commonly conjugated with monoclonal antibodies directed at antigens specific to cancer cells for tumor-directed cytotoxicity. Uses: Adcs cytotoxin. Group: Pharmaceutical. Alternative Names: MMAE; Vedotin; Monomethyl auristatin E; Monomethylauristatin E; N-methyl-L-valyl-N-[(3R,4S,5S)-1-{(2S)-2-[(1R,2R)-3-{[(1S,2R)-1-hydroxy-1-phenylpropan-2-yl]amino}-1-methoxy-2-methyl-3-oxopropyl]pyrrolidin-1-yl}-3-methoxy-5-methyl-1-oxoheptan-4-yl]-N-methyl-L-valinamide. CAS No. 474645-27-7. Pack Sizes: 25 mg. Product ID: BBF-05782. Molecular formula: C39H67N5O7. Mole weight: 717.98. Custom synthesis is available. Send your inquiries for more information. | London |
| Monodes(N-carboxymethyl)valine Daclatasvir | Monodes(N-carboxymethyl)valine Daclatasvir is an impurity of Daclatasvir, a medication that is effective against hepatitis C virus (HCV). Group: Pharmaceutical. Alternative Names: N-[(1S)-2-Methyl-1-[[(2S)-2-[5-[4'-[2-[(2S)-2-pyrrolidinyl]-1H-imidazol-5-yl][1,1'-biphenyl]-4-yl]-1H-imidazol-2-yl]-1-pyrrolidinyl]carbonyl]propyl]carbamic Acid Methyl Ester. CAS No. 1007884-60-7. Pack Sizes: 10 mg. Product ID: B2694-341915. Molecular formula: C33H39N7O3. Mole weight: 581.71. Custom synthesis is available. Send your inquiries for more information. | London |
| MSC2530818 | MSC2530818 is a specific and orally available CDK8 inhibitor with an IC50 of 2.6 nM for CDK8. Group: Pharmaceutical. Alternative Names: MSC2530818; MSC-2530818; MSC 2530818. [(2S)-2-(4-chlorophenyl)pyrrolidin-1-yl]-(3-methyl-2H-pyrazolo[3,4-b]pyridin-5-yl)methanone; SCHEMBL17514257; s8387; AKOS032946259. CAS No. 1883423-59-3. Pack Sizes: 10 mg. Product ID: B0084-007722. Molecular formula: C18H17ClN4O. Mole weight: 340.81. Custom synthesis is available. Send your inquiries for more information. | London |
| MTDIA | MTDIA is a human 5'-methylthioadenosine phosphorylase (MTAP) inhibitor, which is solely responsible for 5'-methylthioadenosine (MTA) metabolism to permit S-adenosylmethionine salvage. It is used as an anticancer candidate. Group: Pharmaceutical. Alternative Names: Methylthio-DADMe-Immucillin A; MT-DADMe-ImmA; (3R,4S)-1-((4-amino-5H-pyrrolo[3,2-d]pyrimidin-7-yl)methyl)-3-hydroxy-4-((methylthio)methyl)pyrrolidin-1-ium. CAS No. 653592-04-2. Pack Sizes: 100 mg. Product ID: B2693-476086. Molecular formula: C13H19N5OS. Mole weight: 294.35. Custom synthesis is available. Send your inquiries for more information. | London |
| MTDIA hydrochloride | MTDIA is a methylthioadenosine phosphorylase (MTAP) inhibitor. MTAP is responsible for 5'-methylthioadenosine (MTA) metabolism to permit S-adenosylmethionine salvage. Transition-state (TS) analogues of MTAP are in development as anticancer drug candidates and MTDIA is one of these TS analogues. Uses: Anticancer drug candidate. Group: Pharmaceutical. Alternative Names: (3R,4S)-1-((4-amino-5H-pyrrolo[3,2-d]pyrimidin-7-yl)methyl)-3-hydroxy-4-((methylthio)methyl)pyrrolidin-1-ium chloride; MTDIA; MTDIA HCl; Methylthio-DADMe-Immucillin A; MT-DADMe-ImmA; MT-DADMe-ImmA HCl. CAS No. 1399840-35-7. Pack Sizes: 50 mg. Product ID: B0084-475405. Molecular formula: C13H20ClN5OS. Mole weight: 329.85. Custom synthesis is available. Send your inquiries for more information. | London |
Our database is helping our users find suppliers everyday.
